✦ LIBER ✦

Concomitant Cisplatin and Hyperfractionated Radiotherapy in Locally Advanced Head and Neck Cancer: 10-Year Follow-Up of a Randomized Phase III Trial (SAKK 10/94)

✍ Scribed by Pirus Ghadjar; Mathew Simcock; Gabriela Studer; Abdelkarim S. Allal; Mahmut Ozsahin; Jacques Bernier; Michael Töpfer; Frank Zimmermann; Michael Betz; Christoph Glanzmann; Daniel M. Aebersold

Book ID: 118455435
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 459 KB
Volume: 82
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2010.11.067

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predictors of Severe Late Toxicity after

Predictors of Severe Late Toxicity after Hyperfractionated Radiotherapy with or without Concomitant Cisplatin in Locally Advanced Head and Neck Cancer: Results of a Randomized Phase III Trial (SAKK 10/94)

✍ P. Ghadjar; M. Simcock; F. Zimmermann; M. Betz; J. Bernier; G. Studer; D.M. Aebe 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Predictors of severe late radiotherapy-r

Predictors of severe late radiotherapy-related toxicity after hyperfractionated radiotherapy with or without concomitant cisplatin in locally advanced head and neck cancer. Secondary retrospective analysis of a randomized phase III trial (SAKK 10/94)

✍ Pirus Ghadjar; Mathew Simcock; Frank Zimmermann; Michael Betz; Stephan Bodis; Ja 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 384 KB

Concomitant Methotrexate and Radiotherap

Concomitant Methotrexate and Radiotherapy in Advanced Head and Neck Cancer: 15-Year Follow-up of a Randomized Clinical Trial

✍ N.K. Gupta; R. Swindell 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 120 KB

Neurotoxicity in a phase I trial of cont

Neurotoxicity in a phase I trial of continuous-infusion cisplatin with hyperfractionated radiotherapy for locally advanced head and neck cancer

✍ Gerald H. Clamon; Lynn Baatz; Henry T. Hoffman; David H. Hussey; Matthew Glascoc 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 569 KB

## Background: Both twice daily fractionated radiotherapy and concurrent cisplatin with once-daily radiotherapy have been shown to improve local disease control in patients with head and neck cancer. the objective of this phase i trial was to determine the maximum tolerated dose of cisplatin which

Five year results of a randomized trial

Five year results of a randomized trial comparing hyperfractionated to conventional radiotherapy over four weeks in locally advanced head and neck cancer

✍ Bernard Cummings; Thomas Keane; Melania Pintilie; Padraig Warde; John Waldron; D 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 297 KB

Accelerated versus Conventional Radiothe

Accelerated versus Conventional Radiotherapy with Concomitant Chemotherapy in Locally Advanced Head and Neck Carcinomas: Results of a Phase III Randomized Trial

✍ J. Bourhis; C. Sire; M. Lapeyre; V. Grégoire; P. Maingon; G. Calais; L. Martin; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 68 KB